THE MOLECULAR EPIDEMIOLOGY OF P53 GENE-MUTATIONS IN HUMAN BREAST-CANCER

Citation
A. Hartmann et al., THE MOLECULAR EPIDEMIOLOGY OF P53 GENE-MUTATIONS IN HUMAN BREAST-CANCER, Trends in genetics, 13(1), 1997, pp. 27-33
Citations number
79
Categorie Soggetti
Genetics & Heredity
Journal title
ISSN journal
01689525
Volume
13
Issue
1
Year of publication
1997
Pages
27 - 33
Database
ISI
SICI code
0168-9525(1997)13:1<27:TMEOPG>2.0.ZU;2-2
Abstract
The P53 tumor-suppressor gene is an advantageous tool for analyzing th e molecular epidemiology of cancer. We describe the utility of the P53 gene as a 'mutagen test' and a prognostic indicator in breast cancer. Aspects of study design and methodology are discussed Two major concl usions emerge: (1) there is an extraordinary diversity of mutational p atterns among coborts, hinting that the unique biology of mammary cell s results in exposure to high doses of a diversity of ingested lipophi lic mutagens; and (2) mutations in the P53 gene predict poor outcome i n breast cancer.